AdMeTech Foundation’s 15th Annual Prostate Cancer Awareness Day Highlights Massachusetts Model of National Leadership in Public Awareness, Medical Education, Research, Clinical Care and Equity
Read MoreWith a $500,000 grant from the GI Research Foundation to Dr. Osman Ahmed, UChicago Medicine will be one of only four hospitals using a new technique to noninvasively treat liver cancer.
Read MoreWith $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a one-two punch to combat BRAF-mutated colorectal cancer and its “dismal prognosis.”
Read MoreAmelia™-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel MetAP2 inhibitor, controlled PI3K-induced hyperglycemia in the first study patient, consistent with pre-clinical data. Further, ctDNA data shows no evidence of residual PIK3CA mutation in blood after 6 weeks of treatment.
Read MoreAdMeTech Foundation's 14th Annual Prostate Cancer Awareness Day Highlights Massachusetts Model of National Leadership in Public Awareness, Education, Research and Clinical Equity
Read MoreSurgiVance, a leading innovator in developing AI-driven, direct-to-digital confocal pathology, announced today that Michael Li, PhD has been appointed Chief Executive Officer.
Read MoreThe Korean biotech company, which has developed a Molecular Diagnostic Tester that detects lung cancer and various cancers at an early stage with a simple breathing test, plans for U.S. clinical trials and FDA registration.
Read MoreThis is the first time in history that Orlando has put the spotlight on boxing ex-world champions that have come together to support those who have fought and those who are still fighting. Why? To support two main charities: Kids Beating Cancer and the Ringside Charitable Trust.
Read MoreAdMeTech Foundation's 13th Annual Prostate Cancer Awareness Day Launches a New Program in Prostate Cancer Equity in Massachusetts
Read More